{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-076309","form_type":"8-K","ticker":"KNSA","cik":"0001730430","company_name":"Kiniksa Pharmaceuticals International, plc","filed_at":"2022-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.043347+00:00","generated_at":"2026-06-24T22:05:49.452116+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Kiniksa shareholders elect three Class I directors, ratify PwC, approve say-on-pay","bullets":["Sanj K. Patel, Thomas R. Malley, Richard S. Levy elected as Class I directors with 33.3M, 31.5M, 34.4M votes for respectively.","Ratification of PricewaterhouseCoopers as auditor for FY2022 approved: 45.3M for, 33k against, 27k abstained.","Advisory say-on-pay proposal approved: 41.5M for, 333k against, 56.6k abstained; 3.45M broker non-votes.","Annual meeting held June 29, 2022; quorum present with Class A and Class B shares voting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-076309","json":"https://secwatch.observer/filing/0001104659-22-076309.json","markdown":"https://secwatch.observer/filing/0001104659-22-076309.md","text":"https://secwatch.observer/filing/0001104659-22-076309.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730430/000110465922076309/0001104659-22-076309-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730430/000110465922076309/tm2220044d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:05:49.452116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}